BREAST CANCER BASE

The advantages of endocrine therapy
Practice has proved that even breast cancer patients after surgery no visible clinical metastases, but a considerable number of patients already exists subclinical metastases. These lesions may develop into a certain period of clinical metastases and threatened the lives of the patients. At present, the auxiliary has become endocrine therapy after surgery for breast cancer patients to receive long-term chances of survival of the most important, if not the only valuable systemic treatment. Because hormone receptor positive or unknown to the patients, supporting endocrine therapy to reduce the risk of recurrence and death risk was crammed with the role of chemotherapy, and its toxicity is much more relaxed.

How breast cancer follow-up?
Follow-up interval : after two years : 3 to 6 months;

After three to five years : six months;

After more than five years : once a year.

Follow-up doctors

Follow-up : timely detection of recurrence and metastasis and timely treatment; Check contralateral breast; Adjuvant therapy; New drugs, new program evaluation.

What is the recurrence of breast cancer?

The spread of cancer cells, causing local recurrence and (or) distant metastasis;

1 / 3 of patients with breast cancer relapse will happen.

Acceleration of breast irradiation (APBI) is a conservative will enable more patients to accept treatment methods, the more rapid, and cost and lower risk of long-term complications. Many interstitial implantation therapy using non-randomized study in the prevention of ipsilateral breast cancer recurrence five years prognosis is very good, but they include only a small number of strictly selected patients with invasive carcinoma.

Radical radiotherapy There are two main forms : ① simple radiotherapy. ② cancer resection plus radiotherapy.

(1) Simple radiotherapy : 1965 Curie Institute in Paris depth using X-ray treatment <BR> 431 cases of breast cancer patients, including 86 cases of Phase II and Phase III 95 cases, five-year survival rates were 67% and 41% are still alive five years were 61% and 35 %. 1978 Curie Institute reported that the use of cobalt 60 gamma ray treatment Ⅱ, Ⅲ 394 cases of breast cancer, 59% of lesions disappeared or destructively relapse later underwent an operation. Its five-year and 10-year rates were alive for 68% and 43%.